statistiche ricercatore

Continente	#
AS - Asia	917
NA - Nord America	486
EU - Europa	211
SA - Sud America	62
Continente sconosciuto - Info sul continente non disponibili	37
AF - Africa	16
OC - Oceania	2
Totale	1.731

Nazione	#
US - Stati Uniti d'America	470
VN - Vietnam	264
CN - Cina	202
SG - Singapore	172
HK - Hong Kong	105
IT - Italia	100
BD - Bangladesh	62
BR - Brasile	51
KR - Corea	38
IN - India	27
FR - Francia	22
DE - Germania	21
NL - Olanda	19
JP - Giappone	12
GB - Regno Unito	11
PH - Filippine	10
AR - Argentina	8
CA - Canada	8
CH - Svizzera	6
CI - Costa d'Avorio	5
FI - Finlandia	5
IE - Irlanda	5
MX - Messico	5
RU - Federazione Russa	5
SE - Svezia	5
IQ - Iraq	4
PK - Pakistan	4
SC - Seychelles	4
SA - Arabia Saudita	3
AT - Austria	2
AU - Australia	2
BG - Bulgaria	2
ID - Indonesia	2
JO - Giordania	2
SN - Senegal	2
TH - Thailandia	2
TW - Taiwan	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
BE - Belgio	1
CL - Cile	1
CO - Colombia	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
ES - Italia	1
HR - Croazia	1
IL - Israele	1
IR - Iran	1
JM - Giamaica	1
KE - Kenya	1
KZ - Kazakistan	1
LY - Libia	1
PL - Polonia	1
PT - Portogallo	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TG - Togo	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
Totale	1.695

Nome	#
The emerging role of cancer nanotechnology in the panorama of sarcoma	254
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives	224
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment	216
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin	194
Abstract 333: Development of a biomimetic 3D scaffold to study breast cancer bone metastasis	169
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors	159
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)	136
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences	124
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need	96
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series	81
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up	78
Totale	1.731

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	24	2	3	0	1	1	2	1	1	0	4	5	4
2022/2023	59	1	5	1	4	5	6	4	1	11	1	6	14
2023/2024	40	2	6	0	0	2	4	0	4	9	11	1	1
2024/2025	205	3	11	8	6	18	5	10	5	13	26	30	70
2025/2026	1.244	100	123	92	92	56	33	317	48	178	62	84	59
2026/2027	159	159	0	0	0	0	0	0	0	0	0	0	0
Totale													1.731

CRIS Current Research Information System